Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to whether COVID-19 could evolve to render the current vaccine ineffective.
Don’t worry about the mutation — yet
Sharon Wright, MD, MPH (Infectious Disease, BILH) discussed whether the current COVID-19 vaccines are effective against the new strain.
Boston infectious disease expert shares latest on new strain of coronavirus
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), lead researcher on the Johnson & Johnson COVID-19 vaccine candidate, said the vaccine in development offers the potential of a single shot vaccine and that not needing subzero freezing will be an advantage for certain parts of the U.S. but will be a vast advantage for the developing world.
Johnson & Johnson Takes Big Step Forward With Its Vaccine Trial, Has Potential to Be Single Shot
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) shared how the COVID-19 experience will almost certainly change the future of vaccine science.
The lightning-fast quest for COVID vaccines — and what it means for other diseases
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to whether taking more than one type of COVID-19 vaccine is better for boosting immunity against the virus.
Should people take more than one type of COVID-19 vaccine?
As millions of the Pfizer and Moderna COVID-19 vaccines are expected to be distributed before year’s end, Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) says these two vaccines alone are not enough for rapid distribution in the U.S. and certainly not globally.
More vaccines need authorization to inoculate all Americans
This front page story and companion video follow the arrival of the Pfizer/BioNTech vaccine to BIDMC, featuring the perspectives of BILH and BIDMC leaders as well as patient-facing staff who received the vaccine.
Vaccinations boost spirits at hospitals throughout Ma...
According to federal officials, at least 40 million doses of the Pfizer and Moderna vaccines should be available by the end of the year and many more are expected next year. A third vaccine, developed in collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) is in a late-stage clinical trial, with results expected early 2021.
What you need to know about Moderna’s COVID-19 vaccine, which is likely to get cleared this week
Hospitals across the U.S. are expecting to receive the first shipments of Pfizer’s COVID-19 vaccine as soon as Monday. Daniel Talmor, MD, MPH (Anesthesiology, Critical Care, BIDMC) shared how the vaccine is the light at the end of the tunnel.
"Without A Vaccine, We Don't Get Out Of This," BIDMC Doctor Says
The earliest shipments of COVID-19 vaccine are expected to arrive at some Massachusetts hospitals starting Monday. Sharon Wright, MD, MPH (Infectious Disease, BILH) discussed how focusing the vaccination process on health workers may help broaden support for the vaccine among the public.
With vaccine to arrive, Mass. goes from ‘defense to offense’ against COVID-19
Moderna appears likely to get a thumbs up for its vaccine from the FDA advisory committee on Dec. 17. Other drug makers hope to get the same authorization for additional vaccines in the coming months, including a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).
FDA authorizes emergency use of first US vaccine for COVID-19
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) speaks with KNX In Depth’s (podcast) hosts Mike Simpson and Charles Feldman about a COVID-19 vaccine. Editor’s note: Interview begins around 24:09.
KNX In Depth: China recovers from COVID so why can't the U.S.?--California hospitals in danger of reaching critical capacity levels--Can your boss force you to get a COVID vaccine?
Could a blood test show if a COVID-19 vaccine works?
A new monkey study offers a ray of hope for...
Dan Barouch named in Bloomberg 50: The People who Changed Global Business in 2020.
The Scientists Leading the Coronavirus Vaccine Race
Marsha Maurer, DPN, RN (CNO, BIDMC) discussed steps BIDMC is taking to keep staff safe during the pandemic.
As the pandemic intensifies and fatigue grows, officials are enforcing new protocols for staff.
This week, the Department of Public Health released their weekly dashboard which classified 97 Massachusetts towns and cities as “red zones.” That number is about eight times higher compared to just one month ago. Michael Gibson, MD (Interventional Cardiology, BIDMC) explained, “when one person gets it, they give it to two, then they give it to four, we are seeing the exponential growth when people run into each other, some of whom are a symptomatic carriers.” Gibson also notes that social economics is a factor in the rise of COVID-19 cases.
Why, week after week, do certain communities remain at high-risk for COVID-19?
Using a massive database of genetic information, researchers at BIDMC identified a genetic variant that the scientists think influences how the immune system responds to COVID-19. To do this research, Robert E. Gerszten, MD (Cardiovascular Medicine, BIDMC), and his coauthors relied on research from earlier in the year that identified a specific genetic variation in the area of the genome that codes for blood type.
We’re just beginning to understand how our genes and COVID-19 mix
